For -omics investigations to achieve their aspired potential, fundamental aspects relating to the study design and statistical analyses in clinical -omics investigations must be dully addressed. The present chapter addresses the most appropriate epidemiological study designs for assessing diagnostic and prognostic biomarkers including cross-sectional, case-control, and cohort studies. Modes of their optimal implementation, as well as potential pitfalls, are detailed. Finally, statistical approaches for evaluating the utility of diagnostic and prognostic biomarkers are also discussed
This thesis presents and analyzes methodological approaches to improve the design and analysis of pr...
The principal conclusions and opportunities that can be drawn from this conference are as follows. T...
Abstract: The design of early-phase studies of putative screening markers in clinical populations is...
For -omics investigations to achieve their aspired potential, fundamental aspects relating to the st...
An epigenomic epidemiologic study may be used to investigate relationships among exposures to enviro...
2018-07-24Two-step study designs, including both two-stage and two-phase designs, have been widely u...
Prospective studies in cancer epidemiology have con-served their study design over the last decades....
Over the last 3 years the research I was involved in could for the most part be classified in terms ...
Pharmacogenomics is the co-development of a drug that targets a subgroup of patients and a device th...
In the early to late phases of conventional clinical trials, improvement of disease status at study ...
In the early to late phases of conventional clinical trials, improvement of disease status at study ...
Proteome analysis is increasingly being used in investigations elucidating the molecular basis of di...
Advances in clinical and basic sciences are raising the potential to use genetic and clinical biomar...
Complementing the chapter on clinical trails, this chapter provides an overview of how to design obs...
The wealth of information generated by high-throughput omics technologies in the context of large-s...
This thesis presents and analyzes methodological approaches to improve the design and analysis of pr...
The principal conclusions and opportunities that can be drawn from this conference are as follows. T...
Abstract: The design of early-phase studies of putative screening markers in clinical populations is...
For -omics investigations to achieve their aspired potential, fundamental aspects relating to the st...
An epigenomic epidemiologic study may be used to investigate relationships among exposures to enviro...
2018-07-24Two-step study designs, including both two-stage and two-phase designs, have been widely u...
Prospective studies in cancer epidemiology have con-served their study design over the last decades....
Over the last 3 years the research I was involved in could for the most part be classified in terms ...
Pharmacogenomics is the co-development of a drug that targets a subgroup of patients and a device th...
In the early to late phases of conventional clinical trials, improvement of disease status at study ...
In the early to late phases of conventional clinical trials, improvement of disease status at study ...
Proteome analysis is increasingly being used in investigations elucidating the molecular basis of di...
Advances in clinical and basic sciences are raising the potential to use genetic and clinical biomar...
Complementing the chapter on clinical trails, this chapter provides an overview of how to design obs...
The wealth of information generated by high-throughput omics technologies in the context of large-s...
This thesis presents and analyzes methodological approaches to improve the design and analysis of pr...
The principal conclusions and opportunities that can be drawn from this conference are as follows. T...
Abstract: The design of early-phase studies of putative screening markers in clinical populations is...